Sign inGet started

Hrustanovic Gorjan

Insider CIK 1821194 · RAIN Director · OLMA Director · KYMR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KYMR Kymera Therapeutics, Inc. A Award deriv2026-06-242026-06-256,068— $06,068SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2026-06-182026-06-2329,500— $029,500SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2025-06-252025-06-2616,000— $016,000SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2025-06-112025-06-1324,150— $024,150SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2024-06-182024-06-2016,000— $016,000SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2024-06-142024-06-1823,000— $023,000SEC↗
RAIN Rain Oncology Inc. D To issuer deriv2024-01-262024-01-2635,000— $00SEC↗
RAIN Rain Oncology Inc. D To issuer deriv2024-01-262024-01-2620,000— $00SEC↗
RAIN Rain Oncology Inc. A Award deriv2023-08-092023-08-1135,000— $035,000SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2023-06-162023-06-2121,520— $021,520SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2023-06-152023-06-2012,000— $012,000SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2022-06-172022-06-2721,520— $021,520SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2022-06-162022-06-1721,520— $021,520SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2022-06-152022-06-1612,000— $012,000SEC↗
RAIN Rain Therapeutics Inc. A Award deriv2022-06-012022-08-1920,000— $020,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2021-06-162021-06-1720,063— $020,063SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2021-06-092021-06-1021,520— $021,520SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2020-11-182020-11-1921,520— $021,520SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2020-11-182020-11-1921,520— $021,520SEC↗
OLMA Olema Pharmaceuticals, Inc A Award deriv2020-11-182020-11-1921,520— $021,520SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2020-08-202020-08-2140,127— $040,127SEC↗